Zheshang Securities said that looking ahead to the future market, the pressure of early market adjustments has basically been released, and in the short term, it is possible to face the future market with a more positive attitude. With large capital getting involved in mainstream ETFs, the market clearly bottomed out and rebounded, which also meant that a short-term bottom gradually formed. Considering that after late June, the market has completed a round of impressive adjustments driven by double innovation, fully releasing the endogenous adjustment pressure brought about by the continuous rise in the previous period. There is limited room for further market decline in the short term. Judging from the above evidence, it has received support near the 20-month line, and there is momentum against the 4,000-point mark; judging from the GEM index, after full adjustments in the early stages, it not only began to rebound above the annual line, but also formed a relatively complete 5-wave structure at the 60-minute level. Once it steps back again, regardless of whether it is a new low or not, it will form a complete bottom structure, and it is expected that a round of rebound above the daily line will begin thereafter. In terms of allocation, the sectors that have now gradually emerged include securities, innovative drugs, and Hang Seng Technology. They can use a mid-line perspective to focus on dips and use them as rebalancing alternatives outside of technology; at the same time, they can participate in the recent rebound of double innovation from the perspective of a short-term overfall rebound.

Zheshang Securities said that looking ahead to the future market, the pressure of early market adjustments has basically been released, and in the short term, it is possible to face the future market with a more positive attitude. With large capital getting involved in mainstream ETFs, the market clearly bottomed out and rebounded, which also meant that a short-term bottom gradually formed. Considering that after late June, the market has completed a round of impressive adjustments driven by double innovation, fully releasing the endogenous adjustment pressure brought about by the continuous rise in the previous period. There is limited room for further market decline in the short term. Judging from the above evidence, it has received support near the 20-month line, and there is momentum against the 4,000-point mark; judging from the GEM index, after full adjustments in the early stages, it not only began to rebound above the annual line, but also formed a relatively complete 5-wave structure at the 60-minute level. Once it steps back again, regardless of whether it is a new low or not, it will form a complete bottom structure, and it is expected that a round of rebound above the daily line will begin thereafter. In terms of allocation, sectors that have now gradually emerged include securities, innovative drugs, and Hang Seng Technology. They can use a mid-line perspective to focus on dips and be rebalancing alternatives outside of technology; at the same time, they can participate in the recent rebound of double innovation from the perspective of a short-term overfall rebound.